Study ID: ABS-AS-303

Study Title

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

Teva Identifier

ABS-AS-303

ClinicalTrials.gov Identifier

NCT02126839

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

05/01/2014 - 02/01/2015

Phase

Phase 3

Study Type

Interventional